吸烟史且肺功能正常者的呼吸急性加重与肺功能下降
基于COPDGene队列中2,939例吸烟量≥10包年且基线肺功能正常者,分析访视1至5年随访间急性加重与FEV1下降及全因死亡的关系。每次额外急性加重与FEV1年下降2.96 ml相关,≥1次重度急性加重与FEV1年下降14.6 ml及死亡率升高相关(17.1% vs 9.8%;调整HR 1.97)。
要点
- 吸烟史且肺功能正常者,呼吸急性加重仍与FEV1加速下降相关
- 重度急性加重者5年随访期间死亡率17.1%,高于无重度急性加重者的9.8%
- 该人群应重视急性加重事件的识别与随访
核心结论
- 吸烟史但肺功能正常者中,呼吸急性加重与肺功能下降相关,重度急性加重与死亡率升高相关。
研究设计与样本
- COPDGene研究参与者分析,纳入吸烟量≥10包年且基线支气管舒张后FEV1/FVC及FEV1均≥正常下限者2,939例,比较访视1至访视2(5年随访)间急性加重与FEV1下降及全因死亡的关系。
主要发现
- 访视1至2间每增加一次急性加重,访视2时FEV1年下降2.96 ml(95%CI 1.81–4.12;P<0.001)。
- 访视1至2间≥1次重度急性加重者较无重度急性加重者FEV1年下降14.6 ml(95%CI 8.56–20.6;P<0.001)。
- ≥1次重度急性加重者死亡率17.1%,无重度急性加重者9.8%(调整HR 1.97;95%CI 1.40–2.77;P<0.001)。
临床怎么用
- 对吸烟史且肺功能正常者,应关注并记录呼吸急性加重事件,重度急性加重提示肺功能下降与死亡风险更高,需加强随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: The impact of respiratory exacerbation on chronic obstructive pulmonary disease (COPD) is well established. The effects of respiratory exacerbations in people with cigarette smoking but normal spirometry are unknown. Objectives: To assess the association of respiratory exacerbations with lung function decline and mortality in people with normal spirometry and current or former cigarette smoking history. Methods: We analyzed data from COPDGene study participants with ⩾10 pack-years of cigarette smoking and normal spirometry at enrollment (Visit 1) defined as post-bronchodilator FEV1/FVC greater than or equal to the lower limit of normal and FEV1 greater than or equal to the lower limit of normal. We examined whether respiratory exacerbations occurring between Visit 1 and the 5-year follow-up visit (Visit 2) were associated with FEV1 decline and all-cause mortality. Measurements and Main Results: Among 2,939 participants with cigarette smoking history and normal lung function at Visit 1, each additional exacerbation between Visits 1 and 2 was associated with a 2.96 ml/yr FEV1 decline (95% confidence interval [CI], 1.81 to 4.12; P < 0.001) at Visit 2. Experiencing one or more severe exacerbations between Visits 1 and 2 was associated with 14.6 ml/yr FEV1 decline relative to those with no severe exacerbations (95% CI, 8.56 to 20.6; P < 0.001). Individuals with one or more severe exacerbations between Visits 1 and 2 had increased mortality compared with those with no severe exacerbations (17.1% vs. 9.8%; adjusted hazard ratio, 1.97; 95% CI, 1.40 to 2.77; P < 0.001). Conclusions: Respiratory exacerbations in people with cigarette smoking but normal spirometry were associated with lung function decline. Experiencing a severe respiratory exacerbation was associated with increased mortality.
引用
- Fortis S, Strand M, Bhatt SP, et al. Respiratory Exacerbations and Lung Function Decline in People with Smoking History and Normal Spirometry. Am J Respir Crit Care Med. 2025. PMID: 39946437. doi:10.1164/rccm.202401-0023OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。